First-line carboplatin and pemetrexed (CP) with or without pembrolizumab (pembro) for advanced nonsquamous NSCLC: Updated results of KEYNOTE-021 cohort G

The requested reference [07725c1feb5b1c52657faabc92b93a3e02fc0d49] no longer exists in our database. It has been replaced by the current reference: [6afaaeb805a0e7e0fd77b2070dc8bf22f379f400]

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2017
This article has no abstract
Epistemonikos ID: 8f8e848a19c2fff51fcdb50e381c2ca010705c82
First added on: Jun 08, 2020